President and CEO Ronald Konezny highlighted a record quarterly revenue of $114 million, marking a 9% year-over-year increase and signaling a return to top-line growth. Konezny reported, "We reported ...

Conventional CRISPR–Cas systems maintain genomic integrity by leveraging guide RNAs for the nuclease-dependent degradation of mobile genetic elements, including plasmids and viruses. Here we describe ...